SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007251
Filing Date
2019-08-06
Accepted
2019-08-06 16:28:23
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20190630x10q.htm 10-Q 2026835
2 EX-31.1 kala-20190630ex311ed8428.htm EX-31.1 22018
3 EX-31.2 kala-20190630ex31245157f.htm EX-31.2 21889
4 EX-32.1 kala-20190630ex321ec9956.htm EX-32.1 10254
5 EX-32.2 kala-20190630ex3225a55d7.htm EX-32.2 10673
  Complete submission text file 0001558370-19-007251.txt   6203468

Data Files

Seq Description Document Type Size
6 EX-101.INS kala-20190630.xml EX-101.INS 1158332
7 EX-101.SCH kala-20190630.xsd EX-101.SCH 44537
8 EX-101.CAL kala-20190630_cal.xml EX-101.CAL 41298
9 EX-101.DEF kala-20190630_def.xml EX-101.DEF 139250
10 EX-101.LAB kala-20190630_lab.xml EX-101.LAB 395330
11 EX-101.PRE kala-20190630_pre.xml EX-101.PRE 282086
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 191002458
SIC: 2834 Pharmaceutical Preparations